Are TTK Healthcare latest results good or bad?

Oct 17 2025 07:14 PM IST
share
Share Via
TTK Healthcare's latest results show a net profit increase of 18.55% year-on-year, but revenue growth is modest at 2.56%, and the operating margin has significantly declined to 2.62%, raising concerns about operational efficiency and reliance on non-operating income. Overall, while there are positive trends in profit and revenue, the underlying operational challenges suggest a need for strategic improvements.
TTK Healthcare's latest financial results for Q2 FY26 present a complex picture of operational performance. The company reported a net profit of ₹20.39 crores, reflecting an 18.55% increase year-on-year, while revenue reached ₹203.57 crores, showing a modest 2.56% growth compared to the same quarter last year. However, this growth is juxtaposed with concerning operational trends.

The operating margin, excluding other income, fell sharply to 2.62%, significantly below the five-year average of 4.2%. This decline indicates a deterioration in core operational efficiency, as the company struggles to maintain profitability amidst rising employee costs, which constituted a larger portion of revenue. The operating profit before depreciation, interest, and tax (excluding other income) was only ₹5.33 crores, highlighting the challenges faced in generating sustainable earnings from core operations.

Additionally, TTK Healthcare's reliance on other income is notable, with 89.25% of profit before tax derived from this source, raising questions about the sustainability of its earnings. The company’s return on equity (ROE) has also declined to 6.33%, well below its historical average, suggesting reduced capital efficiency.

Overall, while TTK Healthcare has shown some positive trends in net profit and revenue growth year-on-year, the underlying operational challenges, particularly the significant drop in operating margins and heavy dependence on non-operating income, indicate a need for strategic improvements. The company saw an adjustment in its evaluation, reflecting these ongoing operational difficulties.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News